Electrophysiology (EP) Market Expected to Reach $22.651 Billion by 2030-Allied Market Research

According to a new report published by Allied Market Research, titled, “Electrophysiology Market by Product, Indication, and End User: Global Opportunity Analysis and Industry Forecast, 2021–2030,"the global EP market was valued at $6.499 billion in 2020, and is estimated to reach $22.651 billion by 2030, growing at a CAGR of 14.4% from 2021 to 2030.

Electrophysiology is defined as the branch of science that deals with the study of electrical pathway associated with heart nervous system. Electrophysiology devices are designed to measure electric current or voltage change on a wide range of scale from single ion channel protein to organs such as heart. The electrophysiology procedure is used to analyze heart’s electrical system and to manage abnormal heart rhythms.

Factors that drive growth of the global electrophysiology market include rise in demand for catheter ablation procedure, advancements in technology in the medical device sector, and surge in demand for early diagnosis. In addition, rise in prevalence of cardiac arrhythmia such as atrial fibrillation, atrial flutter, and ventricular arrhythmia contributes toward growth of the global market. According to the International Journal of Stroke, in 2020, it was analyzed that atrial fibrillation is the most frequent cardiac arrhythmia. Ablation is the most common procedure for treatment of atrial fibrillation, which is expected to increase the need for electrophysiology devices, thus driving growth of the market.

Furthermore, market players are focused on manufacturing of different electrophysiology devices such as ablation catheter, diagnostic catheter, and 3D mapping system. For instance, in January 2022, Abbott laboratory, a pharmaceutical company, announced clearance from the Food and Drug Administrative (FDA) for its EnSite X EP system with EnSite omnipolar technology (OT), in the U.S. and Europe. It is a cardiac mapping platform, designed to help doctors for treatment of cardiac arrhythmia. Moreover, increase in number of geriatric populations and rise in prevalence of chronic conditions such as diabetics and hypertension, who are more prone to atrial fibrillation escalate the electrophysiology (EP) market growth. According to the Journal of J Arrhythm, in August 2021, it was reported that around 70% of population between the ages of 65 and 85 years were diagnosed with atrial fibrillation.

Moreover, rise in healthcare expenditure and development of pharmaceutical and medical technology sectors for manufacturing of advanced catheter is anticipated to drive growth of the electrophysiology market. In addition, expansion of many clinical studies on various types of devices to evaluate their safety and efficacy propels growth of the market. For instance, in October 2020, Biosense Webster, Inc., a part of the Johnson & Johnson Medical Devices Companies announced the ongoing clinical trial on 550 participants for the treatment of paroxysmal atrial fibrillation (PAF) by pulsed field ablation (PFA) system with irreversible electroporation (IRE) (inspIRE). The clinical study started on August 2020, and is estimated to complete by May 2023.

Rise in number of approvals for medical devices is the key factor that further boost growth of the electrophysiology market. In addition, initiatives taken by governments and private organizations to spread knowledge among physicians regarding electrophysiology devices and procedures propel growth of the market.

The global electrophysiology market is segmented into product, indication, end user, and region. On the basis of product, the market is segregated into EP ablation catheters, EP laboratory devices, EP diagnostic catheters, access devices, and others. The EP ablation catheters segment is further subcategorized into cryoablation EP catheters, radiofrequency ablation catheters, microwave ablation systems, laser ablation systems, and navigational advanced mapping accessories. The EP laboratory devices segment is further subcategorized into EP X-Ray systems, 3D mapping systems, EP recording systems, EP remote steering systems, and others.

Further, the EP diagnostic catheters segment is further subcategorized into conventional EP diagnostic catheters, advanced EP diagnostic catheters, and ultrasound EP diagnostic catheters. The EP ablation catheters segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to advancements in technology to manufacture innovative electrophysiology market ablation catheter and increase in number of ablation procedure.

Depending on indication, the electrophysiology market is divided into atrial fibrillation (AF), atrial flutter, Wolff-Parkinson-White syndrome (WPW), atrioventricular nodal reentry tachycardia (AVNRT), and others. The atrial fibrillation segment exhibited highest growth in 2020, and is expected to lead during the forecast period, owing to increase in prevalence of atrial fibrillation, increase in geriatric population, and development of electrophysiology market diagnosis & ablation catheters by the medical device industry. By end user, the market is categorized into hospitals & cardiac centers, ambulatory surgery centers, and others.

The hospitals & cardiac segment was the major contributor in 2020, and is expected to maintain its lead during the forecast period, owing to increase in development of hospital infrastructure and rise in initiatives taken by governments and private organizations to develop hospitals facilities.

The COVID-19 outbreak is anticipated to have a negative impact on growth of the global electrophysiology market. Implementation of lockdown has delayed the ablation procedure; thereby, having a minimal negative impact on the market. The COVID-19 pandemic has stressed healthcare systems in the world and increased the need for advanced hospitals. Many hospitals across the globe, including cardiac centers were restructured to increase hospital capacity for patients diagnosed with COVID-19. This leads to cancellation of many non-essential surgical procedures and the quality of care toward patients other than COVID-19 decreases. This has significantly contributed to decline of the global market.

Key Findings Of The Study

• By product, the EP ablation catheters segment was the highest contributor to the electrophysiology market in 2020.
• On the basis of indication, the atrial fibrillation segment dominated the market in 2020, and is expected to continue this trend during the forecast period.
• Depending on end user, the hospitals & cardiac centers segment led the electrophysiology market in 2020.
• Region wise, North America garnered the largest revenue share in 2020, however, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

North America garnered a major share of the EP market in 2020, and is expected to continue to dominate during the forecast period, owing to rise in prevalence of cardiac arrhythmia, increase in number of approvals for electrophysiology, and strong presence of key players. However, Asia-Pacific is expected to register highest CAGR of 15.1% from 2021 to 2030, owing to increase in prevalence of atrial fibrillation, advancements in technology in the field of electrophysiology market, and initiatives taken by governments to enhance healthcare infrastructure